{
    "nct_id": "NCT04961047",
    "official_title": "Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Patients With Major Medical Illnesses",
    "inclusion_criteria": "1. Provision of signed and date informed consent form.\n2. Stated willingness to comply with all study procedures and availability for the durationof the study.\n3. Associated with Smilow Cancer Hospital with a diagnosis for cancer\n4. Have received chemotherapy, and/or radiation treatment, and/or immuno therapy treatment for cancer\n5. Able to understand and read English\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Stage 4 cancer\n2. Brain cancer\n3. Diagnosis of serious mental illness (ie, psychosis)\n4. Cognitive impairment (ie, diagnosed dementia, intellectual development disorder)\n5. Hearing or vision insufficient to do the computer exercises.\n\nESKD Group\n\nInclusion Criteria:\n\n1. Associated with Yale Nephrology practice and receiving in-center hemodialysis treatment\n2. Have received hemodialysis for at least one month from start of outpatient dialysis and attended 10 of first 12 visits.\n\nExclusion Criteria:\n\n1. Diagnosis of serious mental illness (ie, psychosis)\n2. Cognitive Impairment (ie, diagnosed dementia, intellectual development disorder)\n3. Hearing or vision insufficient to do the computer exercises",
    "miscellaneous_criteria": "Cancer Survivor Group"
}